About EMRA Match
EMRA Match is a collaboration between EMRA, CDEM, CORD and ACEP that was created as an alternative to commercial residency directories which have attempted to rank programs. Instead our goal is to provide students with ready access to easily filterable information that will help them determine which programs will be the best fit for them.
Go To Match
Members of the EMRA Match Task Force
Zach Jarou, Denver Health/UColorado (EMRA)
David Gordon, Duke University (CDEM)
Doug Franzen, UWashington (CDEM)
Adam Kellogg, Baystate/UMass (CORD)
2017 ASAE Power of (A) Silver Award
The 2017 Power of (A) Awards from the American Society of Association Executives recognize a select number of organizations annually that distinguish themselves with innovative, effective and broad-reaching programs and activities that positively impact America and the world.
About EMRA
The Emergency Medicine Residents’ Association (EMRA) is the largest and oldest independent resident organization in the world. EMRA was founded in 1974 and today has a membership of more than 14,000 residents, medical students, fellows, and alumni. EMRA's mission is to be “the voice of emergency medicine physicians-in-training and the future of our specialty.”
Learn More
About CORD
The Council of Emergency Medicine Program Directors (CORD) was formed in 1989 to promote “excellence in emergency medicine education through collaboration, innovation and scholarship.” CORD has grown to serve 205 residency programs and more than a thousand individual members. Learn more at cordem.org.
Learn More
About ACEP
The American College of Emergency Physicians was founded in 1968 to promote the highest quality of emergency care and is the leading advocate for emergency physicians, their patients, and the public.
Learn More
About CDEM
Clerkship Directors in Emergency Medicine (CDEM) is an academy of the Society for Academic Emergency Medicine (SAEM) representing the interests of undergraduate medical educators in emergency medicine. CDEM was formed and became SAEM's first academy in 2008.
Learn MoreRelated Content
Oct 09, 2019
Critical Care Alert: Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19. The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
A complex trial meant to determine whether hydrocortisone can improve outcomes for patients with severe COVID-19 was stopped early - but still shows promise for the course.
